Difficulty: Medium
Average Score: 79%
Practice
A nurse is caring for a client who is about to begin therapy with recombinant factor IX to treat hemophilia B. The client asks the nurse about the risk of disease transmission with recombinant factor IX as compared with plasma derived factor IX. The nurse should explain that the recombinant factor IX practically eliminates the risk for which of the following?
Correct answer
C
Rationale
Rationale:
1. Recombinant factor IX is produced synthetically, not from human blood, hence no risk of Creutzfeldt-Jakob disease.
2. HIV and cytomegalovirus can still be present in plasma-derived factor IX.
3. Anaphylaxis risk is not eliminated by using recombinant factor IX.
1. Recombinant factor IX is produced synthetically, not from human blood, hence no risk of Creutzfeldt-Jakob disease.
2. HIV and cytomegalovirus can still be present in plasma-derived factor IX.
3. Anaphylaxis risk is not eliminated by using recombinant factor IX.